| 发明名称 |
TREATMENT OF MACROPHAGE-RELATED DISORDERS |
| 摘要 |
The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound. |
| 申请公布号 |
US2015037320(A1) |
申请公布日期 |
2015.02.05 |
| 申请号 |
US201414271054 |
申请日期 |
2014.05.06 |
| 申请人 |
Neuraltus Pharmaceuticals, Inc. ;The Regents of the University of California |
发明人 |
McGrath Michael S.;Azhir Arasteh Ari |
| 分类号 |
A61K33/20;A61K45/06;A61K31/137;A61K31/7076;C07K16/28;A61K39/395 |
主分类号 |
A61K33/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of reducing the side effects of an immunomodulator administered to a subject in need thereof, said method comprising administering an oxidative agent to said subject in combination with said immunomodulator. |
| 地址 |
Palo Alto CA US |
